fbpx

Search NGU Website

Academics

Academics

School of Medicine

Mission:
The new MBBCh program aims at producing a distinctive NGU doctor; a scientifically literate, research-informed, patient-centered, and socially responsible professional who can serve the medical needs of individuals and communities both in Egypt and abroad.

The NGU Doctor:
A distinctive scientifically literate, research-informed, patient-centered and socially responsible professional who can serve the health needs of individuals and communities both in Egypt and beyond. The program will enable students to develop as scientists, individuals, practitioners and professionals, possessing a wide range of clinical, professional, generic skills and orientations to enable them to thrive in an ever-changing healthcare environment as a life-long learner.

Prof. Deborah Gill, Medical School Director, UCL, Talking About NGU Collaboration With UCL

Dr. Lamiaa Mohsen,
Dean of the School of Medicine

National and international expert who worked with various governmental and international agencies in the field of health care, education, maternal and child welfare and human resource development.

In September 2016, Lamiaa was appointed as the Founding Dean for Faculty of Medicine Newgiza University which was the first School of Medicine in Egypt to implement the modular integrated curriculum and assessment.

Lamiaa is a member of the RUMP (Reform of Undergraduate Medical Program) committee shared among experts in the preparatory steps for the implementation of the new undergraduate medical curriculum that started in September 2019 in all Egyptian Medical schools.

Lamiaa is a member of the Pediatric Medical Council in the Arab Board since 2014. In this position she is responsible for the preparation, participating and evaluating OF postgraduate training and Assessment in all Arab Countries as well as accreditation of hospitals as training sites.

As a Professor of Pediatrics and Neonatology in Cairo University, Lamiaa was involved in undergraduate teaching and research with twelve international publications in the last five years. Lamiaa was appointed as Director for the Center for Social and Preventive Medicine, Cairo University, a body that links medical higher education to the health needs of the community.

Lamiaa worked with USAID and European Union projects in Indonesia, Jordan, Yemen, and Syria in the fields of Health and child protection. Her leadership skills were solidified through attending The International Health Leadership Program in Cambridge and team-leading The National Egyptian Perinatal Program.

She was appointed 2010-2012 as Secretary-General for the National Council for Childhood and Motherhood, the highest authority in Egypt responsible for protection, promotion and monitoring implementation of Child and adolescent rights in Egypt.

Accreditation: 

Newgiza University (NGU) was established as a private university by a presidential Decree “93” in April 2010. NGU schools are acknowledged by the Ministry of Higher Education (MHE) and the Supreme Council of Universities (SCU).

The university will eventually include twelve Schools: Medicine; Pharmacy; Dentistry; Nursing and Health Science; Economics and Politics; Law; Business and Finance; Engineering; Information Technology; Fine Arts; Archaeology; and Languages and Interpretation. Currently, eight schools are functioning (Medicine, Dentistry, Pharmacy, Business and Finance, Economics and Politics, Engineering, Information Technology, and Fine Arts).

The School of Medicine was acknowledged by decree “3356” in August 2016. Every school will apply for accreditation by the National Authority for Quality Assurance and Accreditation in Education (NAQAAE) after the graduation of the first cohort.

 

University College London (UCL):

The School of Medicine at NGU has an academic collaboration with University College London (UCL), enhancing its academic capabilities, as well as offering world-renowned undergraduate program, providing both the school and students with ample opportunities for development on an academic and personal level.

This collaboration ensured that the highest international standards in teaching and research are met at NGU, with highly qualified faculty members providing instruction and supervision. As part of this collaboration, senior faculty, and staff from UCL worked with their NGU colleagues in strategic planning and organization of the new programs, setting up appropriate infrastructure and education governance structures, developing curricula and learning resources, faculty and senior staff recruitment, faculty development, course evaluation and education quality assurance. Where appropriate, NGU utilizes existing UCL teaching and assessment resources to deliver its programs.

Having currently ranked 9th on the QS World University Rankings 2024, and consistently placing in the top 20 of various global university rankings, UCL is widely recognized for its research capabilities and contributions to sciences and innovations. It was rated 2nd in the UK for research power in the Research Excellence Framework 2021. Moreover, UCL boasts 30 Nobel Prize winners, and was recently selected as University of the Year 2024 (The Times and Sunday Times Good University Guide 2024).

The UCL Medical School is currently ranked 6th in the world in the QS World University Rankings by Subject (2023).

As a student of medicine at NGU you will be joining an exciting and impressive medical school. Your degree will follow a Five-year academic program (followed by  Two-years internship) that includes a stimulating Introductory Module where you will learn alongside students from the other health and life sciences programs followed by a series of ‘horizontal modules’ which focus on body systems and clinical disciplines and vertical themes which focus on important professional topics including clinical skills, professional development, social determinants of health and use of evidence, Student activities and electives.

Your Learning

You will be taught through lectures, tutorials, small-group work, laboratory classes and placements. Later years will involve attachments to teams of consultants and doctors. You will be expected to supplement learning in the university and in healthcare settings with directed self-learning.

You will be assessed by contemporary assessment methods including single best answer questions, objective structured practical examinations and objective structured clinical examinations supplemented with a complete portfolio. The program integrates basic medical sciences and clinical sciences with professional skills and competencies throughout. Small group work and assigned tasks will enhance key generic skills including independent learning, critical thinking, scholarly writing and scientific method.

The MBBCh is five Academic years & two years internship in duration (Eleven semesters). This includes an Introductory Module that is shared with other health education programs at NGU (Dentistry and Pharmacy).

The MBBCh program is an integrated program. This means a deliberate blurring of the boundaries between basic science, and clinical science, between theory and practice and between disciplines. Although delivered in an integrated format, the program includes all the core basic sciences, clinical sciences, practical knowledge and skills and professional and generic skills required to address the intended learning outcomes.

The program contains 308 credit units over 11 semesters. These credit units do not represent only contact hours, but the total learning effort required to achieve the learning outcomes including direct contact hours in classrooms, small groups and practical classes, workplace-based learning in clinical placements, project work, self-paced learning delivered via the Virtual Learning Environment (VLE) and self-directed learning. A credit unit is estimated to represent approximately 25 hours of study.

 

Year 1 | Introductory Module and fundamentals of clinical science 1

Introductory Module: 8 weeks (13CUs)
Infection and Defence: 5 weeks (10CUs)
Behavioral sciences: 3 weeks (6CUs)
Circulation and Breathing: 8 weeks (14CUs)
Fluids, Nutrition and Metabolism: 8 weeks (13CUs)

 

Year 2 | Fundamentals of Clinical Science 2, 3 & Fundamentals of Clinical Science Practice

Movement and Musculoskeletal Biology: 8 weeks (13CUs)
Endocrine Systems and Regulation: 7 weeks (13CUs)
Neuroscience and Behaviour: 9 weeks (14CUs)
Development, Genetics, and Cancer: 6 weeks (10CUs)
Foundations of Clinical Practice: 4 weeks (6CUs)

 

Year 3 | Integrated Clinical Care

Integrated Clinical Care 1, CVS, Respiratory& Acute Care: 12 weeks (22CUs)
Integrated Clinical Care 2, Care of Surgical Patient, Anaesthetics & General Surgery: 12 weeks (21CUs)
Integrated Clinical Care 2; Endocrinology, Haematology, Nephrology & Neurology: 12 weeks (21CUs)

 

Year 4 | The Life Cycle and Community Medicine

Child Health & Mental Health: 12 Weeks (22CUs)
Women’s Health & Mental Health: 12 Weeks (22CUs)
Family Health, Community Health, Public Health & Mental Health: 12 Weeks (22CUs)

 

Year 5 | Specialist Practice and Preparation for Practice

Special Senses (Dermatology, ENT & Ophthalmology): 7 Weeks (10CUs)
Oncology and Palliative Care, Care of the Elderly: 6 Weeks (10CUs)
Senior Clerkship (Medicine & Surgery): 18 Weeks (30CUs)
Emergency Care (Including Trauma and orthopaedics): 6 Weeks (10CUs)
Elective Module: 4 Weeks (6CUs)
Preparation for practice: 4 Weeks (8 CUs)

 

Modules:
Each year contains both horizontal modules (completed within the year) and vertical modules (running through the entire program).
Some elective modules are available to enrich the program and allow students to pursue an area of personal interest or career-related in depth.

The vertical modules:
• Anatomy and Imaging
• Clinical Communication
• Clinical Skills and Practical Procedures
• Practicing in Egypt.
• Pathological Sciences: including histology, microbiology, virology, clinical biochemistry, etc.
• Professional Practice: including professionalism, personal development, ethics & law, etc.
• Social Determinants of Health: including psychological, social, cultural, and environmental factors impacting on health, health inequalities, health promotion, underserved groups, rural health, etc.
• Use of Evidence: accessing, critiquing, using and generating evidence for practice.
• Use of Medicines: pharmacology, therapeutics, prescribing, etc.

Research Team:
o Prof. Dr. Ahmed Ihab Abdelaziz
o Dr. Nada El-Ekiaby
o Dr. Injie Fawzy
o Dr. Mai Saad Zaghloul

Research labs:
o Genomics and Proteomics Lab
o Cell Culture’s Lab
o Biosafety Lab
o Tissue Microarray Lab

Research areas:
o Cancer and Immunotherapy
o Molecular Cardiology
o Autoimmune Diseases
o Infectious Diseases

Projects/grants:
1. DFG Grant BR 2960/3-1- Prof. Dr. Ahmed Ihab, Dr. Nada El-Ekiaby, NGU with Prof. Dr. Kai Breuhahn, Institute of Pathology, Heidelberg 2018
2. ASRT-JESOR _2018-3113 – Prof. Dr. Ahmed Ihab, NGU with Prof. Dr. Hesham Sadek, University of Texas Southwestern Medical Center, USA 2018

1. ceRNAs in HCC – The pinnacle of rivalry
Afify AY., Abdelmaksoud SI., Hesham M., Saad Zaghloul M., El-Ekiaby N. & Abdelaziz AI
Semin Liver Dis. 2019 Jan (In Press)

2. Methylation in MIRLET7A3 Gene Induces the Expression of IGF-II and its mRNA Binding Proteins IGF2BP-2 and 3 in Hepatocellular Carcinoma
Waly AA, El-Ekiaby N, Assal RA, Abdelrahman MM, Hosny KA, El Tayebi HM, Esmat G, Breuhahn K, and Abdelaziz AI
Front. Physiol. 2018| doi: 10.3389/fphys.2018.01918

3. Disruption of Claudin-1 Expression by miRNA-182 Alters the Susceptibility to Viral Infectivity in HCV Cell Models.
Riad SE, Elhelw DS, Shawer H, El-Ekiaby N, Salah A, Zekri A, Esmat G, Amleh A, Abdelaziz AI.
Front Genet. 2018 Mar 20;9:93. doi: 10.3389/fgene.2018.00093.

4. Destabilizing the interplay between miR-1275 and IGF2BPs by Tamarix articulata and quercetin in hepatocellular carcinoma.
Shaalan YM, Handoussa H, Youness RA, Assal RA, El-Khatib AH, Linscheid MW, El Tayebi HM, Abdelaziz AI.
Nat Prod Res. 2017 Aug 18:1-4. doi: 10.1080/14786419.2017.1366478. [Epub ahead of print].

5. MiR-615-5p depresses natural killer cells cytotoxicity through repressing IGF-1R in hepatocellular carcinoma patients.
Rahmoon MA, Youness RA, Gomaa AI, Hamza MT, Waked I, El Tayebi HM, Abdelaziz AI.
Growth Factors. 2017 Jun;35(2-3):76-87. doi: 10.1080/08977194.2017.1354859. Epub 2017 Jul 27.

6. Reduction of CD19 autoimmunity marker on B cells of paediatric SLE patients through repressing PU.1/TNF-α/BAFF axis pathway by miR-155.
Aboelenein HR, Hamza MT, Marzouk H, Youness RA, Rahmoon M, Salah S, Abdelaziz AI.
Growth Factors. 2017 Jun;35(2-3):76-87. doi: 10.1080/08977194.2017.1354859. Epub 2017 Jul 27.

7. Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through transcriptional and translational repression of Occludin.
Elhelw DS, Riad SE, Shawer H, El-Ekiaby N, Salah A, Zekri A, Amleh A, Esmat G, Abdelaziz AI.
Arch Virol. 2018 May;163(5):1405. doi: 10.1007/s00705-018-3798-6.

8. A randomized multicenter study: safety and efficacy of mini-pool intravenous immunoglobulin versus standard immunoglobulin in children aged 1-18 years with immune thrombocytopenia.
Elalfy M, Reda M, Elghamry I, Elalfy O, Meabed M, El-Ekiaby N, El-Hawy MA, Goubran H, El-Ekiaby M.
Transfusion. 2017 Dec ;57(12):3019-3025. doi: 10.1111/trf.14301. Epub 2017 Sep 6.

9. Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients.
Sourour SK, Aboelenein HR, Elemam NM, Abdelhamid AK, Salah S, Abdelaziz AI.
Int J Rheum Dis. 2016 Dec 28 ;4(4):300-305. doi: 10.14218/JCTH.2016.00031. Epub 2016 Dec 27.

10. miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma.
Yacoub RA, Fawzy IO, Assal RA, Hosny KA, Zekri AN, Esmat G, El Tayebi HM, Abdelaziz AI.
J Clin Transl Hepatol. 2016 Dec 28;4(4):300-305. doi: 10.14218/JCTH.2016.00031. Epub 2016 Dec 27.

11. miR-29a Promotes Lipid Droplet and Triglyceride Formation in HCV Infection by Inducing Expression of SREBP-1c and CAV1.
Mahdy MM, El-Ekiaby NM, Hashish RM, Salah RA, Hanafi RS, Azzazy HM, Abdelaziz AI.

J Clin Transl Hepatol. 2016 Dec 28;4(4):293-299. doi: 10.14218/JCTH.2016.00046. Epub 2016 Dec 26.

Tuition Fees:

The School of Medicine tuition fees for the academic year (2023-2024): EGP 210,000 EGP +1,000 USD for Egyptian students. For more information, please click here.

Deadlines:

The deadline for the academic year 2023/2024 will be announced soon.

Fill out the online application form.

For more information about the application process and how to apply to the School of Medicine, please visit the Admissions section.

Dr. Lamia Mohsen, M.B.B.Ch, MD

Dean of the School of Medicine
Load Profile

Dr. Waleed Abd EL Hamid Hassan

Medical Program Manager
Load Profile

Dr. Magda I. Assaf

Ph.D.
Load Profile

Dr. Aisha Eid Saleh Eid

Load Profile

Dr. Ahmed Ihab Abdelaziz Fahmy

Load Profile

Dr. Sandra Younan

Academic Lead
Load Profile

Dr. Mohamed Hafez

Load Profile

Dr. Hend A. M. Attia

M.D.
Load Profile

Dr. Dina Fawzy El-Yasergy

Load Profile

Dr. Nada Magdy El-Ekiaby

Ph.D.
Load Profile

Dr. Manal Louis Louka Abdelmalek

Load Profile

Dr. Manal Moustafa Mahmoud

Load Profile

Dr. Rania Salah

Professor of Anatomy and Embryology
Load Profile

Dr. El Shaimaa Ahmed Fahmy Abo Elkomsan

Load Profile

Dr. Maie Hilmy

Load Profile

Dr. Safaa Sharrah

Physiology assistant lecturer
Load Profile

Dr. Heba S. Omar

M.D.
Load Profile

Dr. Injie Fawzy

Ph.D.
Load Profile

Dr. Ahmed Hamed Bayoumi

Load Profile

Dr. Lamyaa El Toukhy

Load Profile

Dr. Monica Wassim Abdel Malak

Load Profile

Dr. Mai Saad Zaghloul

Load Profile

Dr. Marwan Noureldin

Load Profile

Dr. Mostafa Shohdy

Load Profile

Dr. Sherif Essam

Load Profile

Dr. Lamiaa Reda El Nashar

Load Profile

Dr. Ahmed Shamel Moustafa Hefny

Load Profile

Dr. Wessam N. Salem

Load Profile

Dr. Marwa Mokhtar Abdel Rasoul

Load Profile

Dr. Omneya Kamel

Load Profile

Dr. Sameh Mahmoud Shaheen

Load Profile

Dr. Aya El Nahry

Load Profile

Dr. Yousra Ayman Yousry

Load Profile

Merna Hatem Mohamed Hamad

MSc
Load Profile